Share

March 05, 2013; 80 (10) Article

Thrombogenic microvesicles and white matter hyperintensities in postmenopausal women

Limor Raz, M. Jayachandran, Nirubol Tosakulwong, Timothy G. Lesnick, Samantha M. Wille, Matthew C. Murphy, Matthew L. Senjem, Jeffrey L. Gunter, Prashanthi Vemuri, Clifford R. Jack, Virginia M. Miller, Kejal Kantarci
First published February 13, 2013, DOI: https://doi.org/10.1212/WNL.0b013e3182840c9f
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
345

Share

Article Information

vol. 80 no. 10 911-918
DOI: 
https://doi.org/10.1212/WNL.0b013e3182840c9f
PubMed: 
23408873
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received August 21, 2012
  • Accepted November 21, 2012
  • First Published February 13, 2013.

Article Versions

Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Limor Raz, PhD,
    2. M. Jayachandran, PhD,
    3. Nirubol Tosakulwong,
    4. Timothy G. Lesnick, MS,
    5. Samantha M. Wille,
    6. Matthew C. Murphy, PhD,
    7. Matthew L. Senjem, MS,
    8. Jeffrey L. Gunter, PhD,
    9. Prashanthi Vemuri, PhD,
    10. Clifford R. Jack Jr, MD,
    11. Virginia M. Miller, PhD and
    12. Kejal Kantarci, MD, MS
  1. Limor Raz, PhD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. M. Jayachandran, PhD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Nirubol Tosakulwong,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Timothy G. Lesnick, MS,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Samantha M. Wille,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Matthew C. Murphy, PhD,
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH grants

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. 1. Development of Magnetic Resonance Elastography, licensing agreement with GE (not relevant to this study).

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Matthew L. Senjem, MS,
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Jeffrey L. Gunter, PhD,
    9. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  9. Prashanthi Vemuri, PhD,
    10. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  10. Clifford R. Jack Jr, MD,
    11. Scientific Advisory Boards:

    1. scientific advisory panels: (1) Elan, (2) Lilly, (3) GE, (4) Eisai, (5) Janssen, (6) Johnson and Johnson, (7) Bristol Meyer Squibb, (8) Siemens

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. Investigator in clinical trials sponsored by Baxter, Allon, and the National Institute on Aging

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Allon and Baxter, perform MRI related services for clinical trial

    Research Support, Government Entities:

    1. RO1 AG11378 PI; U01 AG024904-01 co-I; RO1 AG37551 co-I; 1U01HL096917 co-I; U01 AG032438 co-I

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. Johnson and Johnson, 2010

    Legal Proceedings:

    1. NONE

  11. Virginia M. Miller, PhD and
    12. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. 1985 - present Ad Hoc Reviewer: Circulation, Life Sciences, Microvascular Research, Physiology and Behavior, Chest, The American Journal of Cardiology, Journal of Vascular Surgery, 1987 - present Member, Editorial Board, American Journal of Physiology: Heart and Circulatory Physiology, 1991 - present Member, Editorial Board, Journal of Cardiovascular Pharmacology, 2008 - present Member, Editorial Advisory Board, Journal of Pharmacology and Experimental Therapeutics, 2010 - present Member, Editorial Board, Biology of Sex Differences, 2011 - 2014 Member, Editorial Board, The Journal of Clinical Endocrinology & Metabolism, 2011 - present Member, Editorial Board, Journal of Cellular and Molecular Medicine, 2011 - present Member, Editorial Board, Gender Medicine, The Journal for the Study of Sex and Gender Differences, 2012-2013 Member, Editorial Board, Physiology

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  12. Kejal Kantarci, MD, MS
    13. Scientific Advisory Boards:

    1. Data safety monitoring board member for Takeda Global Research & Development Center, Inc.

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. R01 AG040042 (PI); 2011-2016, R21 NS066147 (PI); 2010-2013, Mayo Clinic Alzheimer's Disease Research Center/Project P50 AG16574/P1 (PI); 2009-2014, and R01 AG11378 (Co-I);2008-2013; Specialized Centers of Research (SCOR) on Sex Differences/Project 2 P50AG044170/P2(PI)

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Departments of Physiology and Biomedical Engineering (L.R., M.J., V.M.M.), Health Sciences Research (N.T., T.G.L.), Radiology (S.M.W., M.C.M., M.L.S., J.L.G., P.V., C.R.J., K.K.), and Surgery (V.M.M.), Mayo Clinic, Rochester, MN.
  1. Correspondence to Dr. Kantarci: kantarci.kejal{at}mayo.edu
View Full Text

Article usage

Article usage: February 2013 to April 2023

AbstractFullPdfSource
Feb 2013689037Highwire
Mar 201313913936Highwire
Apr 2013263610Highwire
May 2013157510Highwire
Jun 201310672Highwire
Jul 201310734Highwire
Aug 20138530Highwire
Sep 20137722Highwire
Oct 20136934Highwire
Nov 20136802Highwire
Dec 20135521Highwire
Jan 20149353Highwire
Feb 20146384Highwire
Mar 20147312Highwire
Apr 20144511Highwire
May 20144921Highwire
Jun 20145860Highwire
Jul 20142702Highwire
Aug 20142600Highwire
Sep 20144742Highwire
Oct 20143811Highwire
Nov 20144500Highwire
Dec 20145732Highwire
Jan 20155000Highwire
Jan 2015093pmc
Feb 20155012Highwire
Feb 2015080pmc
Mar 20157102Highwire
Mar 2015073pmc
Apr 20153000Highwire
Apr 2015084pmc
May 20152300Highwire
May 2015041pmc
Jun 20152911Highwire
Jun 2015071pmc
Jul 20154910Highwire
Jul 2015050pmc
Aug 20155011Highwire
Aug 2015032pmc
Sep 20156422Highwire
Sep 2015063pmc
Oct 20153200Highwire
Oct 20150116pmc
Nov 20152410Highwire
Nov 2015088pmc
Dec 20152410Highwire
Dec 2015073pmc
Jan 20163101Highwire
Jan 2016061pmc
Feb 20161311Highwire
Feb 2016062pmc
Mar 20161300Highwire
Mar 2016092pmc
Apr 20161811Highwire
Apr 2016041pmc
May 2016900Highwire
May 2016081pmc
Jun 20161812Highwire
Jun 2016040pmc
Jul 20162000Highwire
Jul 2016020pmc
Aug 20161801Highwire
Aug 2016083pmc
Sep 20161922Highwire
Sep 2016074pmc
Oct 20162603Highwire
Oct 2016081pmc
Nov 20162010Highwire
Nov 2016035pmc
Dec 20162000Highwire
Dec 2016030pmc
Jan 20171200Highwire
Jan 2017063pmc
Feb 20171610Highwire
Feb 20170112pmc
Mar 20171201Highwire
Mar 20170154pmc
Apr 20171300Highwire
Apr 2017033pmc
May 20172020Highwire
May 2017167pmc
Jun 20171100Highwire
Jun 2017233pmc
Jul 2017710Highwire
Jul 201731010pmc
Aug 20171400Highwire
Aug 2017188pmc
Sep 20171511Highwire
Sep 2017144pmc
Oct 20171300Highwire
Oct 2017255pmc
Nov 20171400Highwire
Nov 201761524pmc
Dec 2017900Highwire
Jan 20182030Highwire
Feb 20181900Highwire
Mar 20181701Highwire
Apr 20181620Highwire
Apr 20185911pmc
May 20181800Highwire
Jun 20182300Highwire
Jun 2018066pmc
Jul 20181720Highwire
Aug 20182222Highwire
Aug 201861112pmc
Sep 20181401Highwire
Oct 20182321Highwire
Nov 20181720Highwire
Dec 20182212Highwire
Jan 2019810Highwire
Feb 20191710Highwire
Mar 20191421Highwire
Apr 2019721Highwire
May 2019610Highwire
Jun 20191000Highwire
Jul 2019620Highwire
Aug 20191211Highwire
Sep 2019311Highwire
Oct 20191210Highwire
Nov 20191600Highwire
Dec 20192521Highwire
Jan 20203310Highwire
Feb 20201420Highwire
Mar 2020910Highwire
Apr 2020321Highwire
May 2020810Highwire
Jun 20202510Highwire
Jul 20201400Highwire
Aug 20201600Highwire
Sep 20201640Highwire
Oct 20202011Highwire
Nov 20202112Highwire
Dec 20201531Highwire
Jan 2021940Highwire
Feb 20211641Highwire
Mar 20212611Highwire
Apr 20211600Highwire
May 20211840Highwire
Jun 20212161Highwire
Jul 20213451Highwire
Aug 20213520Highwire
Sep 20213410Highwire
Oct 20211454Highwire
Nov 20212811Highwire
Dec 20212511Highwire
Jan 20221400Highwire
Feb 20223701Highwire
Mar 20222000Highwire
Apr 20223320Highwire
May 20222120Highwire
Jun 20222901Highwire
Jul 20222137Highwire
Aug 20223021Highwire
Sep 20223220Highwire
Oct 20222911Highwire
Nov 20223421Highwire
Dec 20221210Highwire
Jan 20232300Highwire
Feb 20231933Highwire
Mar 20234130Highwire
Apr 20233200Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me

Recommended articles